ArticleMolecular cancer therapeutics2023

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.

Peng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.